publications
| Article Index |
|---|
| publications |
| publications 2008 |
| publications 2007 |
| publications 2006 |
| All Pages |
Sayyed, S. G., Hägele, H., Kulkarni, O. P., Endlich, K., Segerer, S., Eulberg, D., Klussmann, S., & Anders, H.-J. (2009) Podocytes produce homeostatic chemokine stromal cell-derived factor-1/CXCL12, which contributes to glomerulosclerosis, podocyte loss and albuminuria in a mouse model of type 2 diabetes. Diabetologia, Vol. 52(11), 2445-2454.
view PubMed abstract
Schlesinger, J., Fischer, C., Koezle, I., Vonhoff, S., Klussmann, S., Bergmann, R., Pietzsch, H.-J. & Steinbach, J. (2009) Radiosynthesis of new [90Y]-DOTA-based maleimide reagents suitable for the prelabeling of thiol-bearing L-oligonucleotides and peptides. Bioconj. Chem. Vol. 20(7), 1340-1348.
view PubMed abstract
Clauss, S., Gross, O., Kulkarni, O., Avila-Ferrufino, A., Radomska, E., Segerer, S., Eulberg, D., Klussmann, S., & Anders, H.-J. (2009) Ccl2/Mcp-1 blockade reduces glomerular and interstitial macrophages but does not ameliorate renal pathology in collagen4A3-deficient mice with autosomal recessive Alport nephropathy. J. Pathol., Vol. 218(1), 40-47.
view PubMed abstract
Kulkarni, O., Eulberg, D., Selve, N., Zöllner, S., Allam, R., Pawar, R. D., Pfeiffer, S., Segerer, S., Klussmann, S., & Anders, H.-J. (2009) Anti-Ccl2 Spiegelmer permits 75% dose reduction of cyclophosphamide to control diffuse proliferative lupus nephritis and pneumonitis in MRL-Fas(lpr) mice. J. Pharmacol. Exp. Ther., Vol. 328(2), 371-377.
view PubMed abstract

